Active Surveillance as a Management Option for Low-risk Basal Cell Carcinoma.
作者信息
Linos Eleni, Chren Mary-Margaret
机构信息
Department of Dermatology, Stanford University, Stanford, California.
Department of Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee.
出版信息
JAMA Intern Med. 2021 Aug 1;181(8):1032-1033. doi: 10.1001/jamainternmed.2021.2643.
Abstract
摘要
相似文献
1
Active Surveillance as a Management Option for Low-risk Basal Cell Carcinoma.
JAMA Intern Med. 2021 Aug 1;181(8):1032-1033. doi: 10.1001/jamainternmed.2021.2643.
2
Basal cell carcinoma in older adults: how to decide when active surveillance or watchful waiting is appropriate?
Br J Dermatol. 2022 Aug;187(2):244-245. doi: 10.1111/bjd.21056. Epub 2022 May 10.
3
Basal cell carcinoma resolution following diagnostic periocular punch biopsy: is surveillance an option?
Int J Dermatol. 2024 Jun;63(6):827. doi: 10.1111/ijd.17177. Epub 2024 Apr 11.
4
The perspectives of 606 US dermatologists on active surveillance for low-risk basal cell carcinoma.
Br J Dermatol. 2023 Jan 23;188(1):136-137. doi: 10.1093/bjd/ljac002.
5
6
[Basalioma of the skin].
Feldsher Akush. 1990 Jul;55(7):41-4.
7
Choosing treatments for patients: the not so simple case of basal cell carcinoma.
Acta Derm Venereol. 2009;89(5):450-2. doi: 10.2340/00015555-0720.
8
Long-term efficacy of telemedicine for patients with locally advanced basal cell carcinoma during COVID-19 pandemic.
Dermatol Ther. 2022 Nov;35(11):e15786. doi: 10.1111/dth.15786. Epub 2022 Sep 5.
9
[Basal cell carcinoma surgery].
Ugeskr Laeger. 2016 May 16;178(20).
10
Patient Education Series. Nonmelanoma skin cancers.
Nursing. 2012 Jun;42(6):39. doi: 10.1097/01.NURSE.0000414624.08777.7e.
引用本文的文献
1
Cutaneous Basal Cell Carcinoma In Situ: A Review of the World Literature.
Cureus. 2024 Sep 19;16(9):e69691. doi: 10.7759/cureus.69691. eCollection 2024 Sep.
2
Therapeutic Approaches for Non-Melanoma Skin Cancer: Standard of Care and Emerging Modalities.
Int J Mol Sci. 2024 Jun 27;25(13):7056. doi: 10.3390/ijms25137056.
3
Clinical Observation or Further Excision: A Retrospective Review of Margin-positive Squamous and Basal Cell Carcinomas.
Plast Reconstr Surg Glob Open. 2023 Dec 18;11(12):e5473. doi: 10.1097/GOX.0000000000005473. eCollection 2023 Dec.
4
Topical Treatments for Basal Cell Carcinoma and Actinic Keratosis in the United States.
Cancers (Basel). 2023 Aug 2;15(15):3927. doi: 10.3390/cancers15153927.
5
Sun-Exposed versus Sun-Protected Cutaneous Basal Cell Carcinoma: Clinico-Pathological Profile and p16 Immunostaining.
Diagnostics (Basel). 2023 Mar 28;13(7):1271. doi: 10.3390/diagnostics13071271.
6
Basal cell carcinomas in organ transplant recipients versus the general population: clinicopathologic study.
Arch Dermatol Res. 2023 May;315(4):771-777. doi: 10.1007/s00403-022-02403-6. Epub 2022 Oct 25.
本文引用的文献
1
Active surveillance of low-risk papillary thyroid cancer: A meta-analysis.
Surgery. 2020 Jan;167(1):46-55. doi: 10.1016/j.surg.2019.03.040. Epub 2019 Sep 13.
2
The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS).
BMJ Open. 2019 Mar 12;9(3):e026797. doi: 10.1136/bmjopen-2018-026797.
3
Use of Active Surveillance or Watchful Waiting for Low-Risk Prostate Cancer and Management Trends Across Risk Groups in the United States, 2010-2015.
JAMA. 2019 Feb 19;321(7):704-706. doi: 10.1001/jama.2018.19941.
4
Natural history of lesions suspicious for basal cell carcinoma in older adults in Ikaria, Greece.
Br J Dermatol. 2018 Sep;179(3):767-768. doi: 10.1111/bjd.16730. Epub 2018 Jul 12.
5
Potential overdiagnosis of basal cell carcinoma in older patients with limited life expectancy.
JAMA. 2014 Sep 10;312(10):997-8. doi: 10.1001/jama.2014.9655.
6
Treatment of nonfatal conditions at the end of life: nonmelanoma skin cancer.
JAMA Intern Med. 2013 Jun 10;173(11):1006-12. doi: 10.1001/jamainternmed.2013.639.
7
Patient-reported problems after office procedures.
JAMA Intern Med. 2013 Jul 8;173(13):1249-50. doi: 10.1001/jamainternmed.2013.1040.
8
Incidence estimate of nonmelanoma skin cancer in the United States, 2006.
Arch Dermatol. 2010 Mar;146(3):283-7. doi: 10.1001/archdermatol.2010.19.
9
Recurrence rates associated with incompletely excised low-risk nonmelanoma skin cancer.
J Cutan Pathol. 2010 Jan;37(1):59-67. doi: 10.1111/j.1600-0560.2009.01340.x. Epub 2009 Jul 13.
Zotero 插件